4//SEC Filing
Maetzel Andreas 4
Accession 0001209191-21-008665
CIK 0001348911other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 9:33 PM ET
Size
8.6 KB
Accession
0001209191-21-008665
Insider Transaction Report
Form 4
Maetzel Andreas
Senior Vice President Medical
Transactions
- Award
Stock Option (right to buy)
2021-02-07+10,000→ 10,000 totalExercise: $24.23Exp: 2029-05-15→ Common Stock (10,000 underlying) - Award
Stock Option (right to buy)
2021-02-07+10,000→ 10,000 totalExercise: $10.20Exp: 2030-06-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents performance stock options granted to the Reporting Person on May 15, 2019. As a result of the Reporting Person having met the applicable performance criteria, 1/36 of the total stock options vests monthly over a 3-year period commencing on February 7, 2021 until fully vested, subject to the Reporting Person's continued service through each vesting date.
- [F2]Represents performance stock options granted to the Reporting Person on June 16, 2020. As a result of the Reporting Person having met the applicable performance criteria, 1/36 of the total stock options vests monthly over a 3-year period commencing on February 7, 2021 until fully vested, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001576103
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 9:33 PM ET
- Size
- 8.6 KB